{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:02:31Z","timestamp":1772823751679,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico","doi-asserted-by":"crossref","award":["302661\/2016-6"],"award-info":[{"award-number":["302661\/2016-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico","doi-asserted-by":"crossref","award":["400816\/2016-4"],"award-info":[{"award-number":["400816\/2016-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento do Ensino Superior"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cyto.2017.10.017","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T19:02:43Z","timestamp":1509649363000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Ziprasidone, a second-generation antipsychotic drug, triggers a macrophage inflammatory response in vitro"],"prefix":"10.1016","volume":"106","author":[{"given":"Thiago","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Barbisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Ant\u00f4nio Schmidt","family":"do Prado-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f4nica Farina","family":"Azzolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo Em\u00edlio","family":"da Cruz Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Maria Medeiros Frescura","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibele Ferreira","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises Henrique","family":"Mastella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana Beatrice M\u00e2nica","family":"da Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2017.10.017_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14740338.2015.974549","article-title":"Weight gain and antipsychotics: a drug safety review","volume":"14","author":"Musilt","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.cyto.2017.10.017_b0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1017\/S1461145714000157","article-title":"Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome","volume":"17","author":"Paredes","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.cyto.2017.10.017_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/070674371506000503","article-title":"Antipsychotic polypharmacy and corrected QT interval: a systematic review","volume":"60","author":"Takeuchi","year":"2015","journal-title":"Can. J. Psychiatry."},{"key":"10.1016\/j.cyto.2017.10.017_b0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/eip.12251","article-title":"Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications","volume":"10","author":"Tek","year":"2016","journal-title":"Early Interv. Psychiat."},{"key":"10.1016\/j.cyto.2017.10.017_b0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.orcp.2015.08.012","article-title":"Antipsychotic medications and extreme weight gain in two health systems","volume":"10","author":"Arterburn","year":"2016","journal-title":"Obes. Res. Clin. Pract."},{"key":"10.1016\/j.cyto.2017.10.017_b0030","doi-asserted-by":"crossref","first-page":"e150285","DOI":"10.1001\/jamapediatrics.2015.0285","article-title":"Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths","volume":"169","author":"Rubin","year":"2015","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.cyto.2017.10.017_b0035","first-page":"6","article-title":"The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice","volume":"64","author":"Stahl","year":"2003","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/j.cyto.2017.10.017_b0040","article-title":"Kounis syndrome and ziprasidone","author":"Hamera","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.cyto.2017.10.017_b0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/JCP.0000000000000364","article-title":"Drug-induced systemic hypersensitivity reaction associated with ziprasidone: an atypical occurrence","volume":"35","author":"Lister","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cyto.2017.10.017_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.12246","article-title":"Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction","volume":"53","author":"Kim","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.cyto.2017.10.017_b0055","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0269881106075273","article-title":"Urticaria and angio-oedema due to ziprasidone","volume":"21","author":"Akkaya","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.cyto.2017.10.017_b0060","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.pnpbp.2006.01.020","article-title":"Ziprasidone-associated pedal edema in the treatment of schizophrenia","volume":"30","author":"Ku","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiat."},{"key":"10.1016\/j.cyto.2017.10.017_b0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000327604","article-title":"Cytogenetic effects of valproic acid and ziprasidone in human lymphocyte cultures","volume":"64","author":"Karapidaki","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.cyto.2017.10.017_b0070","first-page":"1","article-title":"Ziprasidone induces cytotoxicity and genotoxicity in human peripheral lymphocytes","author":"Kefelioglu","year":"2016","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.cyto.2017.10.017_b0075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s11064-013-1050-z","article-title":"The effects of ziprasidone, clozapine and haloperidol on lipid peroxidation in human plasma (in vitro): comparison","volume":"38","author":"Dietrich-Muszalkska","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cyto.2017.10.017_b0080","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00213-015-4079-7","article-title":"Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels","volume":"233","author":"da Cruz Jung","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cyto.2017.10.017_b0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/abbs\/gmq105","article-title":"Comparative study on modeccin- and phytohemagglutinin (PHA)-induced secretion of cytokines and nitric oxide (NO) in RAW264.7 cells","volume":"43","author":"Kim","year":"2011","journal-title":"Acta Biochem. Biophys. Sin."},{"key":"10.1016\/j.cyto.2017.10.017_b0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/cn500038f","article-title":"Effects of lithium on inflammation","volume":"5","author":"Nassar","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.cyto.2017.10.017_b0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2017.10.017_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tiv.2015.12.001","article-title":"Superoxide-hydrogen peroxide imbalance interferes with colorectal cancer cells viability, proliferation and oxaliplatin response","volume":"32","author":"Azzolin","year":"2016","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.cyto.2017.10.017_b0105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.biochi.2010.04.017","article-title":"Antioxidant properties of 4-methylcoumarins in in vitro cell-free systems","volume":"92","author":"Morabito","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.cyto.2017.10.017_b0110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/NDT.S100846","article-title":"Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review","volume":"12","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.cyto.2017.10.017_b0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/HRP.0000000000000018","article-title":"The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania","volume":"22","author":"Mohammad","year":"2014","journal-title":"Harv. Rev. Psychiat."},{"key":"10.1016\/j.cyto.2017.10.017_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00204","article-title":"How mouse macrophages sense what is going on","volume":"7","author":"Ley","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2017.10.017_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/JAA.S104508","article-title":"Update on the role of alternatively activated macrophages in asthma","volume":"9","author":"Jiang","year":"2016","journal-title":"Asthma Allergy"},{"key":"10.1016\/j.cyto.2017.10.017_b0135","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","article-title":"Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro","volume":"450","author":"Sarv\u00e1ri","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2017.10.017_b0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/bs.acc.2014.11.001","article-title":"Manganese superoxide dismutase and oxidative stress modulation","volume":"68","author":"Bresciani","year":"2015","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.cyto.2017.10.017_b0145","doi-asserted-by":"crossref","first-page":"e107299","DOI":"10.1371\/journal.pone.0107299","article-title":"Methotrexate-related response on human peripheral blood mononuclear cells may be modulated by the Ala16Val-SOD2 gene polymorphism","author":"Barbisan","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.cyto.2017.10.017_b0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10522-015-9561-4","article-title":"The anti-inflammatory effects of resveratrol on human peripheral blood mononuclear cells are influenced by a superoxide dismutase 2 gene polymorphism","volume":"16","author":"Capeleto","year":"2015","journal-title":"Biogerontology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617303319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617303319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T05:20:01Z","timestamp":1659763201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617303319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"alternative-id":["S1043466617303319"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.10.017","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ziprasidone, a second-generation antipsychotic drug, triggers a macrophage inflammatory response in vitro","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}